News RSS Bioethics News.


Young scientists ditch postdocs for biotech start-ups

External Link - Source: Nature

Vindication was three years coming for Ethan Perlstein. On 19 October, his California biotechnology company, Perlara, announced a deal with Novartis. The Swiss drug giant will test a compound that Perlara has identified as a possible treatment for a rare childhood disease, and will invest an undisclosed sum in the smaller firm.

This entry was posted in Cultural, Media, Science and tagged , , . Bookmark the permalink.